Achieving unmet medical
needs and enhancing
consumer benefits.
We have worked on various drug delivery technology platforms including barrier membrane technology, matrix systems and osmotic systems. We have developed nine proprietary technologies for drug delivery and the two most notable among them are:
RubiReten®
A gastro-retentive system for drugs with poor solubility and a limited window of absorption. As on March 31, 2024, our proprietary technologies are backed by 10 patents in various countries including India and the US, which we can leverage for the development of value-added specialty products.
RubiSRL®
For the formulation of sustained release liquids using a combination of ion exchange and membrane diffusion controlled-release technologies.
Apart from the above technologies, Rubicon Research’s experience involves working with Barrier Membrane Technology, Matrix Systems, and Osmotic Systems. Reach out to us to have a conversation about your drug development needs. We work from the first principles of science to develop custom-made solutions because we understand that every problem is unique.
By leveraging our R&D infrastructure and ecosystem, we can take your product to clinic and to the market at the earliest.